Crestline Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,400
Closed -$368K 678
2024
Q4
$368K Buy
19,400
+11,715
+152% +$248K 0.01% 588
2024
Q3
$208K Buy
+7,685
New +$196K 0.01% 497
2022
Q1
Sell
-76,767
Closed -$4.28M 336
2021
Q4
$4.28M Sell
76,767
-10,133
-12% -$557K 0.32% 61
2021
Q3
$5.04M Buy
+86,900
New +$5.36M 0.47% 42
2016
Q4
Sell
-7,143
Closed -$425K 206
2016
Q3
$425K Buy
+7,143
New +$439K 0.05% 156

Other funds holding XRAY

Crestline Management's XRAY Position: Q1 2025 in Review

Crestline Management sold out of Dentsply Sirona (XRAY) in Q1 2025, closing a stake of 19,400 shares — an estimated $368K sold.

Crestline Management first reported a position in XRAY in Q3 2016 and held it in 5 quarters. The position peaked at $5.04M in Q3 2021. 359 funds tracked by Wall St. Rank hold XRAY as of Q1 2025.

  • Crestline Management reported no remaining Dentsply Sirona position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 19,400 Dentsply Sirona shares in Q1 2025, an estimated $368K.
  • Crestline Management first reported a position in Dentsply Sirona in Q3 2016 and held it in 5 quarters.
  • Crestline Management's Dentsply Sirona position peaked at $5.04M in Q3 2021.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.